13 Paul Tudor Jones II Atara Biotherapeutics Trades
The first Atara Biotherapeutics trade was made in Q4 2015.
Since then Paul Tudor Jones II bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q4 2022 and Q1 2023.
Avg closing price
Price range
Sold -7.33 Thousand shares
Q1 2023
Avg closing price
$96.99
Price range
$70.00
-
$136.50
Sold 16.9% shares (-1.49 Thousand shares)
Q4 2022
Avg closing price
$104.21
Price range
$71.25
-
$129.50
Increased shares by 150.7% (+5.31 Thousand shares)
Q3 2022
Avg closing price
$110.87
Price range
$3.89
-
$218.25
Increased shares by 83.2% (+1.6 Thousand shares)
Q2 2022
Avg closing price
$163.23
Price range
$117.25
-
$246.00
New holding (+1.92 Thousand shares)
Q1 2022
Avg closing price
$318.44
Price range
$211.00
-
$422.25
Sold -563 shares
Q1 2021
Avg closing price
$442.02
Price range
$350.00
-
$518.00
Sold 20.8% shares (-148 shares)
Q4 2020
Avg closing price
$461.61
Price range
$316.75
-
$655.75
New holding (+712 shares)
Q3 2020
Avg closing price
$340.54
Price range
$298.00
-
$396.75
Sold -3.04 Thousand shares
Q2 2020
Avg closing price
$252.61
Price range
$188.25
-
$373.25
Increased shares by 71.7% (+1.27 Thousand shares)
Q1 2020